Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus

American Journal of Chinese Medicine

Volumn 40, Issue 5, 2012, Pages 1033-1045

  Wang, Kuo Chih ^a   Chang, Jung San ^a,c   Lin, Liang Tzung ^d   Chiang, Lien Chai ^b   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d IWK HEALTH CENTRE   (Canada)

Author keywords

Antiviral; Cimicifugin; Interferon ; Respiratory Syncytial Virus (RSV); Viral Attachment; Viral Internalization

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; CIMICIFUGIN; HEPARIN; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CIMICIFUGA FOETIDA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MEDICINAL PLANT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ANTIVIRAL AGENTS; BENZOFURANS; CELL LINE; CHROMONES; CIMICIFUGA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPITHELIAL CELLS; FIBRINOLYTIC AGENTS; HEPARIN; HERB-DRUG INTERACTIONS; HUMANS; INTERFERON-BETA; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84865781233     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500760     Document Type: Article

References (22)

1. Bartee, E., M. R. Mohamed and G. McFadden. Tumor necrosis factor and interferon: cytokines in harmony. Curr. Opin. Microbiol. 11:378-383, 2008.
2. Benedict, C. A., T. A. Banks and C. F. Ware. Death and survival: viral regulation of TNF signaling pathways. Curr. Opin. Immunol. 15:59-65, 2003.
3. Blount, R. E., Jr., J. A. Morris and R. E. Savage. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc. Soc. Exp. Biol. Med. 92:544-549, 1956.
4. Chang, J. S., K. C. Wang and L. C. Chiang. Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fibroblast cell line. J. Ethnopharmacol. 119:104-108, 2008.
5. Chen, M., J. S. Chang, M. Nason, D. Rangel, J. G. Gall, B. S. Graham and J. E. Ledgerwood. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. J. Immunol. Methods 362:180-184, 2010.
6. Chiang, L. C., W. Chiang, M. Y. Chang, L. T. Ng and C. C. Lin. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral. Res. 55:53-62, 2002.
7. Collins, P. L. and J. E. Crowe. Respiratory syncytial virus and metapneumovirus. In: D. M. Knipe, P. M. Howley, D. E. Griffin, M. A. Martin, R. A. Lamb, B. Roizman and S. E. Straus (eds.) Fields Virology 1, Vol. 2. Lippincott Williams & Wilkins, Philadelphia, 2007, pp. 2, 1601-1646.
8. Collins, P. L. and B. S. Graham. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82:2040-2055, 2008.
9. Crim, R. L., S. A. Audet, S. A. Feldman, H. S. Mostowski and J. A. Beeler. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. J. Virol. 81:261-271, 2007.
10. De Logu, A., G. Loy, M. L. Pellerano, L. Bonsignore and M. L. Schivo. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 48:177-185, 2000.
11. Duke, J. A. Handbook of Phytochemical Constituents of GRAS Herbs. CRC Press, London, 2001.
12. Empey, K. M., R. S. Peebles, Jr. and J. K. Kolls. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin. Infect. Dis. 50:1258-1267, 2010.
13. Gallelli, L., G. Pelaia, D. Fratto, V. Muto, D. Falcone, A. Vatrella, L. S. Curto, T. Renda, M. T. Busceti, M. C. Liberto, R. Savino, M. Cazzola, S. A. Marsico and R. Maselli. Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells. Int. J. Immunopathol. Pharmacol. 23:471-479, 2010.
14. Graham, B. S., M. D. Perkins, P. F. Wright and D. T. Karzon. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162, 1988.
15. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen and R. H. Parrott. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434, 1969.
16. McCann, K. L. and F. Imani. Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor alpha induction in human epithelial cells. J. Virol. 81:2880-2886, 2007.
17. McFadden, G., M. R. Mohamed, M. M. Rahman and E. Bartee. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 9:645-655, 2009.
18. McLellan, J. S., M. Chen, J. S. Chang, Y. Yang, A. Kim, B. S. Graham and P. D. Kwong. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F. J. Virol. 84:12236-12244, 2010.
19. Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, A. Chandran, E. Theodoratou, A. Sutanto, E. R. Sedyaningsih, M. Ngama, P. K. Munywoki, C. Kartasasmita, E. A. Simoes, I. Rudan, M. W. Weber and H. Campbell. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545-1555, 2010.
20. Oshansky, C. M., W. Zhang, E. Moore and R. A. Tripp. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol. 4:279-297, 2009.
21. Wang, K. C., J. S. Chang, L. C. Chiang and C. C. Lin. Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines. Am. J. Chin. Med. 40:151-162, 2012.
22. Welliver, R. C. Pharmacotherapy of respiratory syncytial virus infection. Curr. Opin. Pharmacol. 10:289-293, 2010.